Status:
COMPLETED
NLCR in Prediction of the Grade of Lung Tumor.
Lead Sponsor:
Medical University of Silesia
Conditions:
Lung Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to assess whether the value of neutrophil-lymphocyte count ratio from the routine preoperative blood test may predict lung tumors' grading.
Detailed Description
Lung cancer remains as one of the leading causes of death among oncology patients. Close connection between inflammation and pathogenesis of some neoplasms was determined in a number of studies. Some ...
Eligibility Criteria
Inclusion
- consecutive thoracic surgery patients with lung cancer grading confirmed by histopathology postoperatively
- preoperative routine complete blood count analysis
Exclusion
- infectious disease
- pregnancy
- autoimmunologic disease
- other known conditions or treatments that may influence the blood count (seropositivity for HIV, chemotherapy, and corticotherapy)
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 16 2018
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03749512
Start Date
October 1 2014
End Date
November 16 2018
Last Update
November 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samodzielny Publiczny Szpital Kliniczny nr 1
Zabrze, Silesian Voivodeship, Poland, 41-800